TP53 and colorectal carcinoma: In summary, fusing the CEABP1 protein to the C-terminus of p28-p53 for specific targeted delivery to CRC cells substantially enhanced the ability of the delivered p53 protein to inhibit CRC cell proliferation and xenograft tumor growth.